Announcement of winner Dieter Lütticken Award

2 May 2005

Intervet Dieter Lütticken Award
New annual prize to reduce the number of testing animals in veterinary medicines awarded to Prof. Andrew Hemphill, Switzerland

Boxmeer,  May 2005 – For the first time Intervet International bv, the animal health business of Akzo Nobel, award an excellent contribution to the principle of 3Rs for the development and production of veterinary medicinal products. The award goes to Prof. Andrew Hemphill, University of Bern, Institute of Parasitology, Faculty of Veterinary Medicine for the development and evaluation of in vitro approaches for culture and investigation of helminthic and protozoan parasites, in particular Neospora caninum and Echinococcus multilocularis. The award, worth 20,000 Euro, will be presented at a ceremony in conjunction with the "5th World Congress on Alternatives", August 21st–25th, 2005, Berlin, Germany.

The final expert jury, with participation of Prof. Coenraad Hendriksen, NVI, Netherlands Vaccine Institute and Prof. Franz J. Conraths, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Germany assessed the work as being characterized by a coherent and integrative set of studies which have been performed in a multi-disciplinary setting with national and international contributors. The application focuses not only on the set up of a new method, but also contributes to a strategic approach for fundamental and applied research. A spin-off to related areas can be expected. The study is highly relevant in terms of the 3Rs, particular “Replacement”.

The award is named after Dieter Lütticken. Dieter Lütticken, committed to research in microbiology and virology, contributed to Intervet research and development for more than a quarter of a century. With his ambition, creativity and broad knowledge in basic and applied science he guided and shaped Intervet's R&D for many years. He established what became tradition – Intervet's sound support and close collaboration with basic research. Dieter Lütticken retired in June 2003 from his position as Vice President and Intervet's Head of R&D.

Application deadline for this year selection is 30.09.2005.
 

Note for the editor
Intervet, a business unit of Akzo Nobel, based in Boxmeer, the Netherlands, with sales of EUR 1,024 million in 2004, is dedicated to research and development, production and marketing of innovative animal health products and feed additives. Intervet's product range for use in livestock, companion animals, poultry and fish includes vaccines, antiparasitics, anti-infectives, endocrine products, other pharmaceutical specialties and feed additives. Intervet operates globally with its own marketing organizations. The company currently employs around 5,000 people.
Internet: www.intervet.com

Akzo Nobel, based in the Netherlands, serves customers throughout the world with healthcare products, coatings and chemicals. Consolidated revenues for 2004 totaled EUR 12.9 billion. The Company currently employs some 61,000 people in more than 80 countries. The financial results for the second quarter will be published on July 20, 2005.  Internet: www.akzonobel.com

Not for publication – For more information please contact
Sabine Schueller   
Communications & Public Affairs 
Intervet International bv   
Tel:  +31 (0)485 587085
Fax:+31 (0)485 585392
communications@intervet.com